REMI

Remedent, Inc. REMI

REMI
Remedent, Inc. LANZ
Lancer Orthodontics, Inc. CYPS
Cyclo3pss Corporation DGEN
Deltagen Inc. CANQF
CanaQuest Medical Corp. RGDXQ
Response Genetics, Inc NMRD
Nemaura Medical Inc. EMGE
Emergent Health Corp UPH
UpHealth, Inc. THCT
THC Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode REMI LANZ CYPS DGEN CANQF RGDXQ NMRD EMGE UPH THCT
6M -99.00 % -85.00 % 400.00 % 0.00 % -99.47 % 0.00 % -50.00 % -90.00 % -81.93 % -66.67 %
YTD -99.67 % -85.00 % 400.00 % 0.00 % -99.50 % 0.00 % 0.00 % -88.76 % 25.65 % -88.89 %
1Y -99.60 % -95.00 % 400.00 % 0.00 % -99.64 % 0.00 % 0.00 % -91.30 % -87.29 % -75.00 %
3Y -99.88 % -97.50 % -80.00 % 0.00 % -99.96 % 0.00 % -100.00 % -98.54 % -99.72 % -53.33 %
5Y -99.86 % -99.75 % -93.33 % -99.00 % -99.92 % -96.67 % -100.00 % -99.93 % -99.69 % -65.00 %
10Y -99.92 % -99.50 % -85.71 % -98.33 % -99.99 % -98.57 % -100.00 % -99.88 % -99.69 % -99.26 %
From the beginning -99.99 % -99.94 % -90.91 % -100.00 % -99.99 % -100.00 % -100.00 % -99.99 % -99.69 % -99.26 %

Dividend

Deltagen Inc.